Devoted Named to Fast Company’s 2023 Best Workplaces for Innovators List

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WALTHAM, Mass.–(BUSINESS WIRE)–Devoted Health, an all-in-one healthcare company delivering complete, coordinated, and customized care for older Americans, today announced that it was named as a Finalist to Fast Company’s 2023 Best Workplaces for Innovators “Health and Wellness” list.


Each year, Fast Company’s Best Workplaces for Innovators list recognizes companies from across the globe who empower employees at all levels to improve processes, create new products, or invent new ways of doing business. Winners are companies with measurable, visible results in their efforts to cultivate internal innovation that creates external impact.

“Devoted is a company built on love, and is focused on dramatically improving the health and well-being of our members by caring for every person like family,” said Ed Park, Devoted Co-Founder and CEO. “This recognition would not have been possible without our team of diverse, mission-focused professionals dedicated to cultivating trust with members. Whether it’s by inviting members to join an elder council in their community, or sending a handwritten card for a major milestone, our team does not just solve problems — we remember how we’d want to be cared for and work to scale that kind of care.

Fast Company selected Devoted based on its industry-leading approach that has led to compelling clinical outcomes for its members. Devoted’s solutions include utilizing Orinoco, an ambitious proprietary technology platform, which powers every aspect of the company’s work, including CRM, EHR, claims, and clinical decision support. Devoted Medical, the company’s clinical organization that works to complement members’ local doctors and hospitals, utilizes a “patient, priorities, care” paradigm that helps patients prioritize and make decisions about their health. As a result, at least 85 percent of Devoted Medical members with diabetes have been able to get their blood sugar levels under control, achieving an average reduction in their HbA1c of 2.1 in a remarkable 93 days. Moreover, at least 77 percent of members with hypertension have gotten their blood pressure under control, reducing systolic blood pressure by an average of 15 mmHg in only 40 days.

Submissions for the 2023 Best Workplaces for Innovators were individually evaluated by a team of Fast Company editors and reporters. Finalists were then reviewed by a panel of judges comprising editors, business leaders, and other innovators.

About Devoted:

Devoted Health is an all-in-one healthcare company on a mission to dramatically improve the health and well-being of older Americans by caring for every person like family. To accomplish this, Devoted Health has designed and built an integrated healthcare solution that combines Devoted Health Medicare Advantage plans, access to top local providers alongside virtual and in-home care delivered by Devoted Medical, full-service guides, and world-class technology that powers it all. The result of bringing all of these exceptional ingredients into one seamless offering is a complete, coordinated, and customized healthcare experience for each Devoted member. Founded in 2017 by brothers Todd and Ed Park, Devoted now serves over 124,000 members across thirteen states including Arizona, Florida, Illinois, Ohio, Texas, Alabama, Colorado, Hawaii, North Carolina, Oregon, Pennsylvania, South Carolina, and Tennessee. To learn more, visit devoted.com.

Contacts

Press:
Alex Bradley
devoted@crosscutstrategies.com

Staff

Recent Posts

Sona Nanotech’s THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal

Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…

1 hour ago

Hemostemix Settlement via Depository Trust Company Plus OTCQB Update

Calgary, Alberta--(Newsfile Corp. - January 13, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE:…

1 hour ago

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance…

2 hours ago

NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025

SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"),…

2 hours ago

Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors

PLAINVIEW, N.Y, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader…

2 hours ago

NeurAxis Inc. Issues Letter to Shareholders

CARMEL, Ind., Jan. 13, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE…

2 hours ago